GSK settles two California lawsuits related to heartburn drug Zantac
WEB3 days ago · Sept 18 (Reuters) - British drugmaker GSK (GSK.L) said on Wednesday it had agreed to settle two lawsuits in California that claimed its discontinued heartburn drug Zantac caused cancer. GSK does ...
Boehringer, GSK, Pfizer Still Face Zantac Cases Despite Mistrial
WEB1 day ago · Zantac manufacturers still face federal, state cases. An Illinois mistrial involving the recalled medication Zantac is the latest court decision involving the recalled drug, but won’t be the last. Illinois resident Ronald Kimbrow in 2023 sued Boehringer Ingelheim Pharmaceuticals Inc., GlaxoSmithKline Holdings, Pfizer Inc., Walgreens Boots ...
Boehringer Ingelheim Faces Second Hung Jury in Chicago Zantac …
WEB2 days ago · Boehringer Ingelheim, GSK, Pfizer and Sanofi all sold brand name Zantac at various times since it was approved in 1983, and have been named in tens of thousands of lawsuits over the alleged cancer ...
GSK Settles Two California Lawsuits Related to Heartburn Drug Zantac
WEB3 days ago · Former Zantac makers GSK, Pfizer, Sanofi and Boehringer Ingelheim are facing about 4,000 claims in California state court and about 2,000 in various other state courts around the country. The bulk ...
GSK shares tumble after Delaware court ruling on Zantac - Financial Times
WEBJun 3, 2024 · GSK shares dropped almost 10 per cent on Monday after a ruling from a Delaware judge left the UK drugmaker exposed to US jury trials over its allegedly carcinogenic heartburn treatment Zantac.
GSK set to face jury trials over heartburn drug Zantac - Financial Times
WEBJun 1, 2024 · GSK and other pharmaceutical groups are set to face jury trials in cases brought by more than 72,000 cancer sufferers who allege a heartburn drug caused their condition, after a judge in Delaware...
Zantac litigation - GSK
WEB11 September 2024 - Statement: Zantac (ranitidine) litigation – Dixon case. GSK plc (LSE/NYSE: GSK) today confirmed it has reached a confidential settlement with Mr. Isaac Dixon, resolving the prostate cancer case filed in Illinois State Court. GSK does not admit any liability in this settlement.
GSK Knew About Zantac Cancer Risk, Attorneys Tell Jury in First Trial
WEBMay 2, 2024 · (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK...
Statement: Zantac (ranitidine) litigation – Delaware State ... - GSK
WEBJun 1, 2024 · Statement: Zantac (ranitidine) litigation – Delaware State Court Daubert Ruling. Scientific consensus is that there is no consistent or reliable evidence that ranitidine increases the risk of any cancer and GSK will continue to vigorously defend itself against all claims.
Another Mistrial in Zantac: Fourth Illinois Jury Fails to Award …
WEB1 day ago · Another jury in the same courthouse handed a verdict last month to a separate Zantac manufacturer, GlaxoSmithKline. And, on May 23, a jury sided with both drug manufacturers in the first Zantac ...
Skip to content